RGLS continues pivoting around that 618 Fib line. Overall, it has held a clear uptrend despite the pullback. Trend line lines up almost perfectly with the latest higher lows put in. RNA companies remain a focus. In this case, it's not covid but kidney diseases.
"In mid-May, Regulus Therapeutics announced an incremental update of its autosomal dominant...
My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15.
For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest).
Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term.
The stock market looks to...
With geopolitical and economic issues, Should we "trace" Glove Stocks "Future Paths" with US Glove Stock ADR/OTC? or "Local" Health Care Index? which is Comprise ≈ A Quarter (28.5% ) ( 4 out of 14 Malaysia Health Care Index Stocks are Gloves Stocks)
The title recently had an explosive exploit touching really important levels, as a result of these unfortunately profit took prevail and the price of the title fell.
Now it seems back the time of collection and the advisor Market Miracle that tries to identify the interests of big players in the market is providing us with an entry signal on the title $CLOV.
METROPOLIS breakout last day with very immense volumes. The stock was being accumulated highly near its last resistance zone(now short term support) and gave BO recently.
- Extremely bullish on higher TFs
- Strong base of 1800 levels
One can go long here @2500 levels and accumulate in dips 2200-2300
Keeping SL 1800 on WCB
BFLY - Current Price $ 10.23 Price Target (short-term) $12.50 Long Term $20
This company created an Ultra sound that is hand held and can give you the same images and accuracy as the ones in use in the USA. The best part about the innovation is the cost reduction. These cost under 3k while most ultra sounds cost a million +. This innovative tech will be used to...
Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves.
You can also see:
There is still rooms for the Williams 224 to climb further.
The historical volatility is lower than it was in...
First of all, I am not an expert when it comes to pharmaceutical companies!
Why did I pick Hepion Pharmaceuticals (@hepionpharma)?
1. From a business perspective, they are healthy (Quick Ration of Assets vs. Liabilities is 9 to 1)
2. They came from a super high share price and are currently on a super low level
3. They are working on a product CRV431 (recently...
MDT price target was just upgraded to $133 by Citi. I see it overshooting that in the long run. Elective surgeries have been put off and doctor visits have been down throughout the pandemic so the amount of pent-up demand for surgical/medical care is going to be through the roof. With an aging population, healthcare is a MUST as a sector to allocate to.
Large Southwestern Health System Signs New Contract for Streamline Health® eValuator™
$STRM today announced it has signed a contract with a 1,300-bed, Epic EMR-based health system in Arizona. The healthcare provider will use eValuator’s cloud-based automated pre- and post-bill coding analysis technology to help improve revenue integrity for their inpatient and...
Sunlink Health Systems, Inc. Announces $2 Million Expansion, Capital and Operating Improvements at Trace Regional Hospital
announced today that its wholly-owned subsidiary, Trace Regional Hospital, has implemented its Trace Forward Capital Plan totaling approximately $2 million to expand, upgrade and improve its physical plant, patient care, ancillary services...
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational Device Exemption (IDE) application, permitting Check-Cap to begin a pivotal study of C-Scan in the U.S.
The pivotal study will evaluate safety and performance of C-Scan as well as subject...
Exela Technologies Wins $90 Million Contract for Cloud-Hosted PCH Global, Delivering Healthcare Solutions for Major US Insurer
$XELA today announced a 10 year, $90 million venture blending automation technologies, SaaS, and services through its PCH Global platform, which officially launched in September of last year.
This effort will accelerate the digital...
More than 50% below the January peak.
RSI, Stochastic and Williams Oscillator at the oversold point.
With the potential to return to $30 in mid-April (almost 40% profit at the current price).
Belonging to a growing sector.
Tangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs.
The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal.
23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics.
- 23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience, and has built a premier genetic database to unlock...